z-logo
Premium
Immunomodulatory effect of vitamin K2: Implications for bone health
Author(s) -
Myneni VD,
Mezey E
Publication year - 2018
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12759
Subject(s) - peripheral blood mononuclear cell , osteoporosis , vitamin d and neurology , medicine , vitamin , endocrinology , flow cytometry , postmenopausal osteoporosis , concanavalin a , t cell , cell growth , immunology , chemistry , bone mineral , immune system , biochemistry , in vitro
Objective In women with postmenopausal osteoporosis, vitamin K2 appears to decrease the incidence of hip, vertebral, and non‐vertebral fractures. Women with postmenopausal osteoporosis have more circulating activated T cells compared with healthy postmenopausal and premenopausal women, but the effects of vitamin K2 on T cells have not been studied. In this study, we have looked at T‐cell suppression by vitamin K2. Materials and methods Peripheral blood mononuclear cells ( PBMC s) from three healthy donors were used. The PBMC s were stimulated with the mitogens phytohemagglutinin and concanavalin A, and T‐cell proliferation was analyzed using flow cytometry based on carboxyfluorescein succinimidyl ester ( CSFE ) dye dilution. Results Vitamin K2 (60 and 100 μM) inhibited T‐cell proliferation. Vitamin K1 at the same concentrations did not inhibit T‐cell proliferation. Conclusion Vitamin K2 has immunomodulatory activities.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here